Last reviewed · How we verify
NCT06237348
Simeox Therapy at Home Versus Standard of Care in NCFB Patients With CMH
NA trial testing Simeox in Non-cystic Fibrosis Bronchiectasis in 50 participants. Completed in 30 December 2024.
30 December 2024
Quick facts
| Lead sponsor | Physio-Assist |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 50 |
| Start date | 15 October 2023 |
| Primary completion | 30 December 2024 |
| Estimated completion | 30 December 2024 |
| Sites | 2 locations across Poland |
Drugs / interventions tested
- Simeox
- Control
Conditions studied
- Non-cystic Fibrosis Bronchiectasis — all drugs for Non-cystic Fibrosis Bronchiectasis →
- Chronic Mucus Hypersecretion — all drugs for Chronic Mucus Hypersecretion →
Sponsor
Physio-Assist
Who can join
18 and older, any sex, with Non-cystic Fibrosis Bronchiectasis or Chronic Mucus Hypersecretion. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This pilot RCT will assess benefits of Simeox technology on lung function, respiratory symptoms, health-related quality of life, subjective efficiency, device adherence at home, Patient satisfaction, tolerance, safety, and telecare feasibility.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT06237348
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Simeox
Trials testing the same drug.
- NCT06801327 — Comparison Between Conventional Respiratory Physiotherapy and the Simeox Device in Patients With Bronchiectasis · NA · recruiting
- NCT04084041 — Efficacy of Simeox Airway Clearance Therapy in Children With Cystic Fibrosis · NA · completed
- NCT04793724 — Respiratory Physiotherapy Performed by Simeox In Patients With Primary Ciliary Dyskinesia · NA · completed
Other recruiting trials for Non-cystic Fibrosis Bronchiectasis
Currently open trials in the same condition.
- NCT07547436 — A Study to Access Activity and Safety With SAR445399 Compared With Placebo in Participants Aged 18 to 80 Years of Age Wi · Phase 2 · recruiting
- NCT07245407 — A Translational Study for Phenotyping and Endotyping Chinese Patients With NCFBE · recruiting
- NCT07048262 — Dose Range Finding, Efficacy, and Safety Study of Nebulized CSL787 in Adults With Non-cystic Fibrosis Bronchiectasis (NC · Phase 2 · recruiting
- NCT06603246 — A Study to Test the Safety and Effects of Inhaled GDC-6988 in Participants With Muco-obstructive Disease · Phase 1, PHASE2 · recruiting
- NCT06660992 — A Study to Assess the Efficacy and Safety of HSK31858 in Participants With Non-Cystic Fibrosis Bronchiectasis · Phase 3 · recruiting
Other Physio-Assist trials
Trials by the same sponsor.
- NCT04742270 — Home Airway Clearance in Patients With Bronchiectasis (Home-Care Bronchiectasis) · NA · completed
- NCT04096664 — Home Airway Clearance in CF Patients · NA · completed
- NCT04095078 — Ancillary Home Airway Clearance in CF Patients ( HomeCareSIMEOX ) · NA · completed
- NCT04084041 — Efficacy of Simeox Airway Clearance Therapy in Children With Cystic Fibrosis · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06237348 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Physio-Assist
- Last refreshed: 4 March 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06237348.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing